Medicare Enrolled
Dr. Keith Kirby, MD
Interventional Pain Medicine Physician · Savannah, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kirby from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kirby?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kirby
Dr. Keith Kirby is an interventional pain medicine physician in Savannah, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kirby performed 437 Medicare services across 274 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kirby received a total of $9,443 from 60 pharmaceutical and/or device companies across 540 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kirby is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 437 Medicare services
$9,443 industry payments
Medicare Practice Summary
Medicare Utilization ↗437
Medicare services
Bottom 27% in GA for interventional pain medicine physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
274
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~23 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
118 | $83 | $225 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
98 | $0 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $108 | $260 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
36 | $97 | $800 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
36 | $56 | $800 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
28 | $71 | $800 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
22 | $186 | $800 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
22 | $66 | $800 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $50 | $150 |
| New patient office visit, complex (60-74 min) | 13 | $138 | $320 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,443
Total received (2018-2024)
Avg $1,349/year across 7 years
Top 26% in GA for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
540
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,403 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$40 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$576
2023
$895
2022
$1,429
2021
$1,536
2020
$1,426
2019
$1,752
2018
$1,829
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$157
Collegium Pharmaceutical, Inc.
$101
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$96
ABBVIE INC.
$74
IDORSIA PHARMACEUTICALS US INC
$46
Lundbeck LLC
$46
Forte Bio-Pharma LLC
$40
PFIZER INC.
$17
Top 3 companies account for 61.4% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,767
Collegium Pharmaceutical, Inc.
$1,038
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$740
Boston Scientific Corporation
$570
Daiichi Sankyo Inc.
$443
PFIZER INC.
$398
BOSTON SCIENTIFIC CORPORATION
$375
BioDelivery Sciences International, Inc.
$327
Scilex Pharmaceuticals Inc.
$320
Forte Bio-Pharma LLC
$290
Sentynl Therapeutics, Inc.
$247
ABBVIE INC.
$196
Medtronic USA, Inc.
$189
IDORSIA PHARMACEUTICALS US INC
$157
Amgen Inc.
$156
Teva Pharmaceuticals USA, Inc.
$154
RedHill Biopharma Inc.
$144
Allergan, Inc.
$137
Shionogi Inc
$137
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$132
SCILEX PHARMACEUTICALS INC.
$111
ARBOR PHARMACEUTICALS, INC.
$80
Takeda Pharmaceuticals U.S.A., Inc.
$77
Vertical Pharmaceuticals, LLC
$77
Lundbeck LLC
$71
Eisai Inc.
$70
Purdue Pharma L.P.
$68
Zyla Life Sciences
$63
AstraZeneca Pharmaceuticals LP
$61
Assertio Therapeutics, Inc.
$58
AbbVie Inc.
$52
Egalet US Inc
$50
Novartis Pharmaceuticals Corporation
$46
Allergan Inc.
$40
Hikma Pharmaceuticals USA
$40
TerSera Therapeutics LLC
$38
Almatica Pharma LLC
$34
Virtus Pharmaceuticals LLC
$31
Supernus Pharmaceuticals, Inc.
$31
INSYS Therapeutics Inc
$30
West Therapeutics Development, LLC
$30
ASSERTIO THERAPEUTICS, Inc.
$29
Ultragenyx Pharmaceutical Inc.
$29
Flexion Therapeutics, Inc.
$27
Lilly USA, LLC
$26
Ferring Pharmaceuticals Inc.
$23
Medtronic, Inc.
$23
Biohaven Pharmaceuticals, Inc.
$21
Bioventus LLC
$20
Azurity Pharmaceuticals, Inc.
$19
Averitas Pharma Inc.
$19
Biohaven Pharmaceutical Holding Company Ltd.
$16
Zimmer Biomet Holdings, Inc.
$16
GRT US Holding, Inc.
$16
IBSA Pharma Inc.
$16
Merck Sharp & Dohme Corporation
$15
Kowa Pharmaceuticals America, Inc.
$14
Zyla Life Sciences, Inc.
$13
Arbor Pharmaceuticals, Inc.
$12
Horizon Therapeutics plc
$11
Top 3 companies account for 37.5% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · Aimovig · Amitiza · Axium INS DRG IPG · BELBUCA · BELSOMRA · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · Cryvista · DUEXIS · Dayvigo · Durolane · EMGALITY · ETERNA · EUFLEXXA · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · Gel One · General - Pain Management · Gralise · Horizant · INTELLIS · Kloxxado · LEVORPHANOL TARTRATE · LICART · LIORESAL · LORZONE · LUCEMYRA · LYRICA · Levorphanol · Levorphanol Tartrate · Livalo · MOTEGRITY · MOVANTIK · Morphabond ER · Movantik · NALOCET · NAPRELAN · NT1100 NT2000iX Simplicity · NURTEC ODT · Nalocet · Neuromodulation Dspsbls and Accs · Nucynta · Octrode SCS Leads · PRIALT · PROCLAIM · PROLATE · Penta SCS Leads · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RELISTOR · REYVOW · SPECTRA WAVEWRITER · SPRIX · SUBSYS · SYMPROIC · Subsys · Symproic · TROKENDI XR · UBRELVY · VANTA ADAPTIVESTIM · VYEPTI · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional pain medicine physicians within 10 mi
2
Per 100K population
0.7
County median income
$69,575
Nearest hospital
CANDLER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kirby is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kirby experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kirby performed 118 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kirby receive payments from pharmaceutical companies?
Yes. Dr. Kirby received a total of $9,443 from 60 companies across 540 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kirby's costs compare to other interventional pain medicine physicians in Savannah?
Dr. Kirby's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kirby) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Savannah
Browse interventional pain medicine physicians in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in GA
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in GA
Which GA interventional pain medicine physicians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology